Monthly Archives: August 2017

Defeat GBM Research Collaborative – Core-By-Core Progress: Discovery Core

By Tom Halkin | Published August 31, 2017

In NBTS’ first “Expert Series” blogs in 2017, we examined the topic of neurosurgery. Now, we’ll take a look, Core-by-Core, on the progress being made by our Defeat GBM (glioblastoma) Research Collaborative. Just a few weeks ago, we provided a comprehensive update on the discoveries and advances being made by Defeat GBM (and and infographic […]

Posted in Brain Tumor Information, Clinical Trials, Leadership Spotlight, Our Impact, Research | Tagged astrocytoma, brain cancer, brain tumor, Cancer, chemotherapy, Defeat GBM, GBM, glioblastoma, glioblastoma multiforme, glioma, high-grade glioma, precision medicine, radiation, Treatment |

Brain Tumor Research Highlights: August 2017

By Tom Halkin | Published August 29, 2017

To see July’s Brain Tumor Research Highlights, click here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship […]

Posted in Brain Tumor Information, Clinical Trials, Regulatory Affairs, Research | Tagged biopharma, brain cancer, brain tumor, Cancer, chemotherapy, GBM, glioblastoma, glioblastoma multiforme, glioma, high-grade glioma, precision medicine, Treatment |